Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8(2):98–101

CAS  PubMed  Google Scholar 

Eiro N, Gonzalez LO, Fraile M, Cid S, Schneider J, Vizoso FJ (2019) Breast cancer tumor stroma: cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities. Cancers 11(5):664. https://doi.org/10.3390/cancers11050664

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao Y, Keller ET, Garfield DH, Shen K, Wang J (2013) Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 32(1–2):303–315. https://doi.org/10.1007/s10555-012-9415-3

Article  PubMed  PubMed Central  Google Scholar 

Brisson BK, Mauldin EA, Lei W, Vogel LK, Power AM, Lo A, Dopkin D, Khanna C, Wells RG, Puré E, Volk SW (2015) Type III collagen directs stromal organization and limits metastasis in a murine model of breast cancer. Am J Pathol 185(5):1471–1486. https://doi.org/10.1016/j.ajpath.2015.01.029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soysal SD, Tzankov A, Muenst SE (2015) Role of the tumour microenvironment in breast cancer. Pathobiology 82(3–4):142–152. https://doi.org/10.1159/000430499

Article  CAS  PubMed  Google Scholar 

McMillin DW, Negri JM, Mitsiades CS (2013) The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 12(3):217–228. https://doi.org/10.1038/nrd3870

Article  CAS  PubMed  Google Scholar 

van der Spek YM, Kroep JR, Tollenaar RAEM, Mesker WE (2020) Chemotherapy resistance and stromal targets in breast cancer treatment: a review. Mol Biol Rep 47(10):8169–8177. https://doi.org/10.1007/s11033-020-05853-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Micke P, Strell C, Mattsson J, Martín-Bernabé A, Brunnström H, Huvila J, Sund M, Wärnberg F, Ponten F, Glimelius B, Hrynchyk I, Mauchanski S, Khelashvili S, Garcia-Vicién G, Molleví DG, Edqvist PH, O Reilly A, Corvigno S, Dahlstrand H, Botling J, … Mezheyeuski A (2021) The prognostic impact of the tumour stroma fraction: a machine learning-based analysis in 16 human solid tumour types. EBioMedicine 65:103269. https://doi.org/10.1016/j.ebiom.2021.103269

Forsare C, Vistrand S, Ehinger A, Lövgren K, Rydén L, Fernö M, Narbe U (2022) The prognostic role of intratumoural stromal content in lobular breast cancer. Cancers (Basel) 14(4):941. https://doi.org/10.3390/cancers14040941

Article  CAS  PubMed  Google Scholar 

Downey CL, Simpkins SA, White J, Holliday DL, Jones JL, Jordan LB, Kulka J, Pollock S, Rajan SS, Thygesen HH, Hanby AM, Speirs V (2014) The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 110(7):1744–1747. https://doi.org/10.1038/bjc.2014.69

Article  CAS  PubMed  PubMed Central  Google Scholar 

Millar EK, Browne LH, Beretov J, Lee K, Lynch J, Swarbrick A, Graham PH (2020) Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer. Cancers (Basel) 12(12):3749. https://doi.org/10.3390/cancers12123749

Article  CAS  PubMed  Google Scholar 

Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC (2004) Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53(4):581–586. https://doi.org/10.1136/gut.2003.028365

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reis S, Gazinska P, Hipwell JH, Mertzanidou T, Naidoo K, Williams N, Pinder S, Hawkes DJ (2017) Automated classification of breast cancer stroma maturity from histological images. IEEE Trans Biomed Eng 64(10):2344–2352. https://doi.org/10.1109/TBME.2017.2665602

Article  PubMed  Google Scholar 

Dekker TJ, Charehbili A, Smit VT, ten Dijke P, Kranenbarg EM, van de Velde CJ, Nortier JW, Tollenaar RA, Mesker WE, Kroep JR (2015) Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial. Mol Oncol 9(6):1120–1128. https://doi.org/10.1016/j.molonc.2015.02.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ (2011) Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 178(3):1221–1232. https://doi.org/10.1016/j.ajpath.2010.11.076

Article  PubMed  PubMed Central  Google Scholar 

Natal RA, Vassallo J, Paiva GR, Pelegati VB, Barbosa GO, Mendonça GR, Bondarik C, Derchain SF, Carvalho HF, Lima CS, Cesar CL, Sarian LO (2018) Collagen analysis by second-harmonic generation microscopy predicts outcome of luminal breast cancer. Tumour Biol 40(4):1010428318770953. https://doi.org/10.1177/1010428318770953

Article  CAS  PubMed  Google Scholar 

Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14(5):518–527. https://doi.org/10.1038/nm1764

Article  CAS  PubMed  Google Scholar 

Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, Tanke HJ, Tollenaar RA (2007) The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumour stage. Cell Oncol 29(5):387–398. https://doi.org/10.1155/2007/175276

Article  PubMed  PubMed Central  Google Scholar 

Hagenaars SC, Vangangelt K, Van Pelt GW, Karancsi Z, Tollenaar R, Green AR, Rakha EA, Kulka J, Mesker WE (2022) Standardization of the tumour-stroma ratio scoring method for breast cancer research. Breast Cancer Res Treat 193(3):545–553. https://doi.org/10.1007/s10549-022-06587-3

Article  PubMed  PubMed Central  Google Scholar 

Aurello P, Berardi G, Giulitti D, Palumbo A, Tierno SM, Nigri G, D’Angelo F, Pilozzi E, Ramacciato G (2017) Tumour-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients. Surgeon 15(6):329–335. https://doi.org/10.1016/j.surge.2017.05.007

Article  PubMed  Google Scholar 

Strous M, Faes T, Gubbels A, van der Linden R, Mesker WE, Bosscha K, Bronkhorst CM, Janssen-Heijnen M, Vogelaar FJ, de Bruïne AP (2022) A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance. Clin Transl Oncol 24(6):1047–1058. https://doi.org/10.1007/s12094-021-02746-y

Article  CAS  PubMed  Google Scholar 

Scheer R, Baidoshvili A, Zoidze S, Elferink M, Berkel A, Klaase JM, van Diest PJ (2017) Tumour-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: a retrospective cohort study. World J Gastrointest Oncol 9(12):466–474. https://doi.org/10.4251/wjgo.v9.i12.466

Article  PubMed  PubMed Central  Google Scholar 

Almangush A, Alabi RO, Troiano G, Coletta RD, Salo T, Pirinen M, Mäkitie AA, Leivo I (2021) Clinical significance of tumour-stroma ratio in head and neck cancer: a systematic review and meta-analysis. BMC Cancer 21(1):480. https://doi.org/10.1186/s12885-021-08222-8

Article  PubMed  PubMed Central  Google Scholar 

Zhang T, Xu J, Shen H, Dong W, Ni Y, Du J (2015) Tumour-stroma ratio is an independent predictor for survival in NSCLC. Int J Clin Exp Pathol 8(9):11348–11355

PubMed  PubMed Central  Google Scholar 

Smit MA, Philipsen MW, Postmus PE, Putter H, Tollenaar RA, Cohen D, Mesker WE (2020) The prognostic value of the tumour-stroma ratio in squamous cell lung cancer, a cohort study. Cancer Treat Res Commun 25:100247. https://doi.org/10.1016/j.ctarc.2020.100247

Article  PubMed  Google Scholar 

Nastały P, Smentoch J, Popęda M, Martini E, Maiuri P, Żaczek AJ, Sowa M, Matuszewski M, Szade J, Kalinowski L, Niemira M, Brandt B, Eltze E, Semjonow A, Bednarz-Knoll N (2021) Low tumour-to-stroma ratio reflects protective role of stroma against prostate cancer progression. J Pers Med 11(11):1088. https://doi.org/10.3390/jpm11111088

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Liu J, Li J, Chen Y, Guan X, Wu X, Hao C, Sun Y, Wang Y, Wang X (2014) Tumour-stroma ratio is an independent predictor for survival in early cervical carcinoma. Gynecol Oncol 132(1):81–86. https://doi.org/10.1016/j.ygyno.2013.11.003

Article  PubMed  Google Scholar 

Chen Y, Zhang L, Liu W, Liu X (2015) Prognostic significance of the tumour-stroma ratio in epithelial ovarian cancer. Biomed Res Int 2015:589301. https://doi.org/10.1155/2015/589301

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu J, Liang C, Chen M, Su W (2016) Association between tumour-stroma ratio and prognosis in solid tumour patients: a systematic review and meta-analysis. Oncotarget 7(42):68954–68965. https://doi.org/10.18632/oncotarget.12135

Article  PubMed  PubMed Central  Google Scholar 

Vangangelt K, Green AR, Heemskerk I, Cohen D, van Pelt GW, Sobral-Leite M, Schmidt MK, Putter H, Rakha EA, Tollenaar R, Mesker WE (2020) The prognostic value of the tumour-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer. Int J Cancer 146(8):2296–2304. https://doi.org/10.1002/ijc.32857

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dekker TJ, van de Velde CJ, van Pelt GW, Kroep JR, Julien JP, Smit VT, Tollenaar RA, Mesker WE (2013) Prognostic significance of the tumour-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 139(2):371–379. https://doi.org/10.1007/s10549-013-2571-5

Article  CAS  PubMed  Google Scholar 

Kramer C, Vangangelt K, van Pelt GW, Dekker T, Tollenaar R, Mesker WE (2019) The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat 173(1):55–64. https://doi.org/10.1007/s10549-018-4987-4

Article  CAS  PubMed  Google Scholar 

Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC (2014) The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer. Br J Cancer 111(1):157–165. https://doi.org/10.1038/bjc.2014.279

Article  CAS